This opportunity is no longer accepting applications.
grant PAR-23-084

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

This grant supports investigator-initiated clinical trials that need 6 or 7 years to complete. The trials can be in any phase but must be hypothesis-driven and aligned with the participating Institute or Center's research goals. Applicants should consult with Institute or Center staff before applying. This grant is not for clinical trials that require less than 6 years.

This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC.…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR

Dates

Opportunity Released: January 12, 2023
Open for Submission: January 12, 2023
Application Window Closes: January 13, 2026
Submission Deadline: January 13, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.